Residency, Internal Medicine, Mount Sinai Hospital
Fellowship, Pulmonary, Mount Sinai Hospital
Awards
2009 Best Doctors New York Magazine
2003 The Dr Sidney Grossman Distinguished Humanitarian Award Alumni Association, Mount Sinai School of Medicine
2001 2000 Physician of the Year Award Nursing Department, MSMC
2001 Healthcare Foundation of New Jersey Humanism in Medicine Faculty Award\t
1999 Saul Horowitz Jr. Memorial Award Mount Sinai School of Medicine
1996 Distinguished Service Award The Samuel Bronfman Department of Medicine, MSMC
1989 Distinguished Teacher Award The Samuel Bronfman Department of Medicine, MSMC
1987 - 1990 Henry and Catherine Gaisman Fellowship
1982 - 1987 Pulmonary Academic Award (NIH)\t
1980 - 1981 American Lung Association Fellowship
1975 Dr. Alan Guttmacher Award
1974 Alpha Omega Alpha
1971 - 1975 Max Som Scholarship
After completing her pulmonary fellowship at Mount Sinai
School of Medicine and The Mount Sinai Medical Center, Dr. Padilla pursued her
studies in lung transplantation by attending the programs at Toronto GeneralHospital
and StanfordUniversity. She was the co-founder of
the program at The Mount Sinai Hospital in New York City. During her fellowship
training, Dr. Padilla conducted research in pathology, developing models of
pulmonary diseases under the mentorship of Dr. Jerome Kleinerman. She also participated
in clinical research in Sarcoidosis and Interstitial Lung Diseases. She is a
United Network for Organ Sharing (UNOS) certified transplant pulmonologist and
a member of the International Society of Heart and Lung Transplantation
(ISHLT). She served on the editorial and scientific advisory boards of the
World Association of Sarcoidsosis and Other Granulomatous Diseases (WASOG). Dr.
Padilla is a committee member of the Interstitial Lung Disease Network of the AmericanCollege of Chest Physicians, and is also
a steering committee member of the Pulmonary Fibrosis Indentification: Lessons
for Optimizing Treatment (PILOT). She serves on the medical advisory boards of
the Coalition for Pulmonary Fibrosis, the Sarcoidosis Research Foundation, the Hermansky
Pudlak Syndrome Network, and the Scleroderma Foundation, Tri-State Chapter. She
is a graduate of the Executive Leadership of American Medicine (ELAM) program.
Dr.
Padilla is board certified in Internal Medicine, Pulmonary Medicine and
Critical Care Medicine. She is the Director of the Advanced Lung /Interstitial
Lung Disease Program and the Medical Director of the Lung Transplantation
Program at The Mount Sinai Medical Center. She is also involved in the Sarcoidosis
Service and the adult Cystic Fibrosis program. She is a consultant to other
transplant programs at our institution, and is also the principal investigator
of clinical research projects. Dr. Padilla specializes in the treatment of
diffuse interstitial lung diseases, including idiopathic interstital pneumonia,
acute interstital pneumonia, lymphocytic interstital pneumonia, non-specific
interstital pneumonia, organizing pneumonia, bronchiollitis obliterans, and
hypersensitivity pneumonia.She also
specializes in lung diseases associated with rheumatologic disorders, such as rheumatoid
arthritis, dermatomyositis, mixed connective tissue disease, and systemic lupus
erythematosus. In addition, she also treats drug-induced lung disease,
mycobacterial lung disease, Langerhans cell hystiocytosis,
lymphangioleimyomatosis, pulmonary vasculitis, alveolar hemorrhage, and
pulmonary alveolar proteinosis.
Training
Education and Training
MD, Mount Sinai School of Medicine
Residency, Internal Medicine, Mount Sinai Hospital
Fellowship, Pulmonary, Mount Sinai Hospital
Board Certification
Pulmonary Disease
Clinical Practice
Subspecialty
Pulmonary Disease
Clinical Interests
Sarcoidosis
Cystic Fibrosis
Asbestos Disease
Cardiopulmonary Disease
Dermatomyositis
Interstitial Lung Disease
Lung Transplant
Organ Transplants
Pulmonary Hypertension
Scleroderma
Board Certification
Pulmonary Disease
Research
Dr. Padilla's research interests include investigation of fibrogenesis and the various manifestations of this process in different diseases (Idiopathic Pulmonary Fibrosis, Sarcoidosis, Collagen Vascular associated pulmonary fibrosis, genetic associated pulmonary fibrosis, Hermansky Pudlak Syndrome, bronchiolitis obliterans among others). She conducts clinical investigations in the treatment and course of these diseases and participates in collaborative multicenter studies to advance the understanding and knowledge of these illnesses. She is the principal investigator of the INSPIRE trial investigating the safety and efficacy of Interferon gamma on the survival of patients with Idiopathic Pulmonary Fibrosis. Additional studies investigating early markers of interstitial lung disease, therapies for secondary pulmonary hypertension and the efficacy of certain agents on the pulmonary fibrosis associated with Hermansky Pudlak Syndrome, are in development.
Padilla ML, Lesser M, Galiki N, Kleinerman J. High Cathepsin-B activity in alveolar macrophages occurs with elastase - induced emphysema but not with bleomycin - induced pulmonary fibrosis in hamsters. Amer J of Path 1988 Apr; 131(1): 92-101.
Lesser M, Padilla ML, Cardozo C, Orlowski M. Induction of emphysema in hamsters by intratracheal instillation of Cathepsin-B. Am Rev Respir Dis 1992 Mar; 145(3): 661-668.
Cardozo C, Padilla ML, Choi HS H, Lesser M. Goblet cell hyperplasia in large intrapulmonary airways after intratracheal injection of Cathepsin-B into hamsters. Am Rev Respir Dis 1992 Mar; 145(3): 675-679.
Henzlova MJ, Padilla ML, Freilich A, Gass AL, Courtney MC, Diamond JA, Machac J. Dobutamine thallium 201 perfusion imaging in candidates for lung transplantation. J Heart Lung Transplant 1995 Mar-Apr; 14(2): 251-256.
Padilla ML, Schilero GJ, Teirstein AS. Sarcoidosis and Transplantation. Sarcoidosis Vasculitis and Diffuse Lung Disease 1997 Mar; 14(1): 16-22.
Lenner R, Padilla M, Gass A. Complication in heart transplant recipients. Chest 2001 Aug; 120(2): 508-513.
Sulica R, Teirstein A, Padilla M. Lung transplantation in interstitial lung disease. Current Opinion in Pulmonary medicine 2001 Sep; 7(5): 314-322.
The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.
Clinical Trials
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.
